Skip to content
Home/Companies/Biotech/TIBEAY Biosciences

TIBEAY Biosciences

Biotech·Netherlands·Active·New
Entry
2026
Hold
New
Status
Active

Who owns TIBEAY Biosciences?

TIBEAY Biosciences is a Dutch Biotech company, currently owned by MIG Capital since 2026.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
MIG Capital
Investor
MIG Capital
MIG Fonds 18 · 2024 · VC

Key facts

HQNetherlands
SectorBiotech
StatusActive

More from MIG Fonds 18

Other portfolio companies in the same fund.

CoreMedic
CoreMedic
Active
MedTechGermany· 2025
NcodiN
Active
Deep TechFrance· 2025

More MIG Capital portfolio companies

From the same investor, across funds.

ASTRA Therapeutics
Active
BiotechGermany· 2025
GlassPoint
Active
ClimateTechUS· 2024
HawkCell
Active
MedTechFrance· 2024
SciRhom
Active
BiotechGermany· 2024
Look Up Space
Active
Aerospace & DefenceFrance· 2023
mbiomics
mbiomics
Active
BiotechGermany· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns TIBEAY Biosciences?

TIBEAY Biosciences is currently owned by MIG Capital, through MIG Fonds 18, since 2026.

When did MIG Capital acquire TIBEAY Biosciences?

MIG Capital acquired TIBEAY Biosciences in 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue